| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.8 |